| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.5 |